当前位置:首页 - 行情中心 - 健帆生物(300529) - 财务分析

健帆生物

(300529)

  

流通市值:108.66亿  总市值:169.62亿
流通股本:5.12亿   总股本:7.99亿

健帆生物(300529)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润3.89亿元,每股收益0.51元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益312241.85万元,未分配利润228456.06万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产526726.74万元,负债214484.89万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入1,134,416,582.38547,835,977.142,677,320,710.762,195,690,243.92
营业总成本691,481,834.59331,034,826.71,711,410,834.561,282,068,331.55
其他经营收益
营业利润481,171,504.06236,505,672.181,045,365,774.88984,361,550.35
利润总额461,903,988.17225,129,406.851,006,964,187.92954,619,509.02
净利润388,668,556.92188,177,307.35814,186,376.79788,826,841.3
每股收益
其他综合收益--1,054,450.84-
综合收益总额388,668,556.92188,177,307.35815,240,827.63788,826,841.3
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计2,634,307,821.893,073,800,310.582,783,662,467.053,291,871,424.79
非流动资产:
非流动资产合计2,632,959,589.592,609,626,928.292,599,786,609.412,301,254,367.22
资产总计5,267,267,411.485,683,427,238.875,383,449,076.465,593,125,792.01
流动负债:
流动负债合计739,598,918.35779,769,719.98766,793,322.83872,869,134.42
非流动负债:
非流动负债合计1,405,250,0031,371,528,176.231,281,991,218.311,427,029,484.55
负债合计2,144,848,921.352,151,297,896.212,048,784,541.142,299,898,618.97
所有者权益(或股东权益):
归属于母公司股东权益合计3,122,714,168.663,531,977,322.493,333,906,225.543,289,267,081.77
股东权益合计3,122,418,490.133,532,129,342.663,334,664,535.323,293,227,173.04
负债和股东权益合计5,267,267,411.485,683,427,238.875,383,449,076.465,593,125,792.01
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,402,751,627.12658,571,672.873,031,200,823.772,366,547,595.13
经营活动现金流出小计864,470,191.73389,517,884.061,980,212,402.371,494,942,789.57
经营活动产生的现金流量净额538,281,435.39269,053,788.811,050,988,421.4871,604,805.56
投资活动产生的现金流量:
投资活动现金流入小计1,788,774,548.16651,287,207.783,780,380,657.981,574,436,729.11
投资活动现金流出小计2,678,769,929.412,182,381,942.84,907,852,936.293,752,188,395.04
投资活动产生的现金流量净额-889,995,381.25-1,531,094,735.02-1,127,472,278.31-2,177,751,665.93
筹资活动产生的现金流量:
筹资活动现金流入小计73,948,636.4843,071,108.07419,418,426.61344,425,852.51
筹资活动现金流出小计701,421,484.3427,128,528.121,409,239,488.081,072,115,403.69
筹资活动产生的现金流量净额-627,472,847.8615,942,579.95-989,821,061.47-727,689,551.18
汇率变动对现金及现金等价物的影响93,947.11145,379.17427,871.75-787,737.51
现金及现金等价物净增加额-979,092,846.61-1,245,952,987.09-1,065,877,046.63-2,034,624,149.06
期末现金及现金等价物余额696,573,394.64429,713,254.161,675,666,241.25706,919,138.82
补充资料:
现金及现金等价物的净增加额-979,092,846.61--1,065,877,046.63-
最新报告期:2025-08-21
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
国金证券何冠洲1.071.311.572025-08-21
TOP↑